{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:09:20Z","timestamp":1788487760919,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Plan for NRRP Complementary Investments","award":["PNC0000003"],"award-info":[{"award-number":["PNC0000003"]}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana Ricerca Cancro","doi-asserted-by":"crossref","award":["IG23573"],"award-info":[{"award-number":["IG23573"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>With the advances in immunotherapy and the challenge of poor responsiveness in oral squamous cell carcinoma (OSCC) patients, understanding the tumor microenvironment is crucial. Radiogenomics offers the potential to provide pre-operative, non-invasive image-derived immune biomarkers. To this aim, the present study explores the capability of MRI-based radiomics to describe patients\u2019 immune state in OSCC. Seven MRI-based radiomic, 29 immune-related gene expression signatures were computed and deconvolution analysis was performed for a subset of OSCC from the BD2Decide database. A correlation-driven analysis identified key associations between radiomic and immune-related signatures and cell populations. Radiomic classifiers of the gene expression signatures were then developed to evaluate their capability to stratify patients based on immune status.  MRI-based radiomic models showed promising results in predicting a gene expression signature associated with significant prognostic value for HNSCC patients who underwent radiotherapy (AUC\u2009=\u20090.92), suggesting these models\u2019 potential in distinguishing radioresistant from radiosensitive patients, aiding treatment decisions. Additionally, radiomic signatures reflected immune infiltrating cells in our cohort (M1, CD8\u2009+\u2009T, B cells). MRI-radiomic signatures and associated models could become non-invasive methods to evaluate the prognosis and treatment choice in OSCC patients. Based on our promising results, and upon external validation, MRI-radiomics could enhance personalized medicine approaches.<\/jats:p>","DOI":"10.1038\/s41598-025-96821-x","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T06:30:26Z","timestamp":1744439426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Anna","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lenoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina D. A.","family":"Corino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mattavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ravanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Licitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"De Cecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"96821_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"96821_CR2","doi-asserted-by":"publisher","first-page":"1233085","DOI":"10.3389\/fimmu.2023.1233085","volume":"14","author":"J Bao","year":"2023","unstructured":"Bao, J., Betzler, A. C., Hess, J. & Brunner, C. Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma. Front. Immunol. 14, 1233085 (2023).","journal-title":"Front. Immunol."},{"key":"96821_CR3","doi-asserted-by":"publisher","first-page":"1021609","DOI":"10.3389\/fonc.2022.1021609","volume":"12","author":"M Damasio","year":"2022","unstructured":"Damasio, M. et al. The role of T-cells in head and neck squamous cell carcinoma: from immunity to immunotherapy. Front. Oncol. 12, 1021609 (2022).","journal-title":"Front. Oncol."},{"key":"96821_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","volume":"23","author":"AT Ruffin","year":"2023","unstructured":"Ruffin, A. T. et al. Improving head and neck cancer therapies by Immunomodulation of the tumour microenvironment. Nat. Rev. Cancer. 23, 173\u2013188 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"96821_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11912-018-0654-5","volume":"20","author":"J Moskovitz","year":"2018","unstructured":"Moskovitz, J., Moy, J. & Ferris, R. L. Immunotherapy for head and neck squamous cell carcinoma. Curr. Oncol. Rep. 20, 22 (2018).","journal-title":"Curr. Oncol. Rep."},{"key":"96821_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11912-020-00938-3","volume":"22","author":"NE Wondergem","year":"2020","unstructured":"Wondergem, N. E., Nauta, I. H., Muijlwijk, T., Leemans, C. R. & van de Ven, R. The immune microenvironment in head and neck squamous cell carcinoma: on subsets and subsites. Curr. Oncol. Rep. 22, 81 (2020).","journal-title":"Curr. Oncol. Rep."},{"key":"96821_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1200\/JCO.22.02328","volume":"41","author":"E Yilmaz","year":"2023","unstructured":"Yilmaz, E. et al. Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers: ASCO guideline. J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol. 41, 1132\u20131146 (2023).","journal-title":"J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol."},{"key":"96821_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"MS Lawrence","year":"2015","unstructured":"Lawrence, M. S. et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015).","journal-title":"Nature"},{"key":"96821_CR9","doi-asserted-by":"publisher","first-page":"102263","DOI":"10.1016\/j.ctrv.2021.102263","volume":"99","author":"G Bruixola","year":"2021","unstructured":"Bruixola, G. et al. Radiomics and radiogenomics in head and neck squamous cell carcinoma: potential contribution to patient management and challenges. Cancer Treat. Rev. 99, 102263 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"96821_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00066-020-01638-4","volume":"196","author":"S Tanadini-Lang","year":"2020","unstructured":"Tanadini-Lang, S. et al. Radiomic biomarkers for head and neck squamous cell carcinoma. Strahlentherapie Und Onkol. 196, 868\u2013878 (2020).","journal-title":"Strahlentherapie Und Onkol"},{"key":"96821_CR11","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1038\/s41598-022-21159-7","volume":"12","author":"A Rabasco Meneghetti","year":"2022","unstructured":"Rabasco Meneghetti, A. et al. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC. Sci. Rep. 12, 16755 (2022).","journal-title":"Sci. Rep."},{"key":"96821_CR12","doi-asserted-by":"publisher","first-page":"1015436","DOI":"10.3389\/fimmu.2022.1015436","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma. Front. Immunol. 13, 1015436 (2022).","journal-title":"Front. Immunol."},{"key":"96821_CR13","doi-asserted-by":"publisher","first-page":"104877","DOI":"10.1016\/j.oraloncology.2020.104877","volume":"110","author":"E Katsoulakis","year":"2020","unstructured":"Katsoulakis, E. et al. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncol. 110, 104877 (2020).","journal-title":"Oral Oncol."},{"key":"96821_CR14","first-page":"3353","volume":"280","author":"R Hang","year":"2023","unstructured":"Hang, R. et al. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning. Eur. Arch. oto-rhino-laryngology Off J. Eur. Fed. Oto-Rhino-Laryngological Soc. Affil Ger. Soc. Oto-Rhino-Laryngology - Head Neck Surg. 280, 3353\u20133364 (2023).","journal-title":"Eur. Arch. oto-rhino-laryngology Off J. Eur. Fed. Oto-Rhino-Laryngological Soc. Affil Ger. Soc. Oto-Rhino-Laryngology - Head Neck Surg."},{"key":"96821_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/RCT.0000000000001149","volume":"45","author":"CY Wang","year":"2021","unstructured":"Wang, C. Y. & Ginat, D. T. Preliminary computed tomography radiomics model for predicting pretreatment CD8\u2009+\u2009T-Cell infiltration status for primary head and neck squamous cell carcinoma. J. Comput. Assist. Tomogr. 45, 629\u2013636 (2021).","journal-title":"J. Comput. Assist. Tomogr"},{"key":"96821_CR16","doi-asserted-by":"publisher","first-page":"110093","DOI":"10.1016\/j.ejrad.2021.110093","volume":"146","author":"YM Zheng","year":"2022","unstructured":"Zheng, Y. M. et al. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur. J. Radiol. 146, 110093 (2022).","journal-title":"Eur. J. Radiol."},{"key":"96821_CR17","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1007\/s00330-022-08651-4","volume":"32","author":"YM Zheng","year":"2022","unstructured":"Zheng, Y. M. et al. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur. Radiol. 32, 5362\u20135370 (2022).","journal-title":"Eur. Radiol."},{"key":"96821_CR18","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun, R. et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 19, 1180\u20131191 (2018).","journal-title":"Lancet Oncol."},{"key":"96821_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hed.26515","volume":"43","author":"S Cavalieri","year":"2021","unstructured":"Cavalieri, S. et al. Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: the big data to decide EU project. Head Neck. 43, 601\u2013612 (2021).","journal-title":"Head Neck"},{"key":"96821_CR20","doi-asserted-by":"publisher","first-page":"109701","DOI":"10.1016\/j.ejrad.2021.109701","volume":"139","author":"P Bos","year":"2021","unstructured":"Bos, P. et al. Improved outcome prediction of oropharyngeal cancer by combining clinical and MRI features in machine learning models. Eur. J. Radiol. 139, 109701 (2021).","journal-title":"Eur. J. Radiol."},{"key":"96821_CR21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s00330-021-08292-z","volume":"32","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. An MRI-based radiomics-clinical nomogram for the overall survival prediction in patients with hypopharyngeal squamous cell carcinoma: a multi-cohort study. Eur. Radiol. 32, 1548\u20131557 (2022).","journal-title":"Eur. Radiol."},{"key":"96821_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/0284186X.2021.1924401","volume":"60","author":"S Alfieri","year":"2021","unstructured":"Alfieri, S. et al. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients. Acta Oncol. 60, 1192\u20131200 (2021).","journal-title":"Acta Oncol."},{"key":"96821_CR23","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.3390\/cancers14246119","volume":"14","author":"TY Siow","year":"2022","unstructured":"Siow, T. Y. et al. MRI radiomics for predicting survival in patients with locally advanced hypopharyngeal cancer treated with concurrent chemoradiotherapy. Cancers (Basel). 14, 6119 (2022).","journal-title":"Cancers (Basel)"},{"key":"96821_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/hed.27299","volume":"45","author":"C Mossinelli","year":"2023","unstructured":"Mossinelli, C. et al. The role of radiomics in tongue cancer: A new tool for prognosis prediction. Head Neck. 45, 849\u2013861 (2023).","journal-title":"Head Neck"},{"key":"96821_CR25","doi-asserted-by":"publisher","first-page":"109638","DOI":"10.1016\/j.radonc.2023.109638","volume":"183","author":"M Bologna","year":"2023","unstructured":"Bologna, M. et al. Prognostic radiomic signature for head and neck cancer: development and validation on a multi-centric MRI dataset. Radiother Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 183, 109638 (2023).","journal-title":"Radiother Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"96821_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40364-023-00494-5","volume":"11","author":"A Corti","year":"2023","unstructured":"Corti, A. et al. MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures. Biomark. Res. 11, 69 (2023).","journal-title":"Biomark. Res."},{"key":"96821_CR27","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1038\/s41598-024-60009-6","volume":"14","author":"A Corti","year":"2024","unstructured":"Corti, A. et al. MRI radiomics in head and neck cancer from reproducibility to combined approaches. Sci. Rep. 14, 9451 (2024).","journal-title":"Sci. Rep."},{"key":"96821_CR28","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/s41598-020-63148-8","volume":"10","author":"L Li","year":"2020","unstructured":"Li, L. et al. Comprehensive Immunogenomic landscape analysis of prognosis-related genes in head and neck cancer. Sci. Rep. 10, 6395 (2020).","journal-title":"Sci. Rep."},{"key":"96821_CR29","doi-asserted-by":"publisher","first-page":"11507","DOI":"10.18632\/aging.202842","volume":"13","author":"R Fang","year":"2021","unstructured":"Fang, R. et al. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma. Aging (Albany NY). 13, 11507\u201311527 (2021).","journal-title":"Aging (Albany NY)"},{"key":"96821_CR30","doi-asserted-by":"publisher","first-page":"687245","DOI":"10.3389\/fcell.2021.687245","volume":"9","author":"S Li","year":"2021","unstructured":"Li, S. et al. Molecular subtypes of oral squamous cell carcinoma based on immunosuppression genes using a deep learning approach. Front. Cell. Dev. Biol. 9, 687245 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"96821_CR31","doi-asserted-by":"crossref","unstructured":"Lin, X. et al. Clinical significance and immune landscapes of stemness-related and immune gene set-based signature in oral cancer. Clinical and translational medicine 11, e343 (2021).","DOI":"10.1002\/ctm2.343"},{"key":"96821_CR32","doi-asserted-by":"crossref","unstructured":"Bai, S. et al. Bioinformatic analysis reveals an immune\/Inflammatory-related risk signature for oral cavity squamous cell carcinoma. J. Oncol. 3865279 (2019).","DOI":"10.1155\/2019\/3865279"},{"key":"96821_CR33","doi-asserted-by":"crossref","unstructured":"Lv, S., Qian, Z., Li, J., Piao, S. & Li, J. Identification and validation of a Hypoxia-immune-based prognostic mRNA signature for oral squamous cell carcinoma. J. Oncol. 5286251 (2022).","DOI":"10.21203\/rs.3.rs-596220\/v1"},{"key":"96821_CR34","doi-asserted-by":"crossref","unstructured":"Feng, J., Li, Y. & Wen, N. Characterization of cancer stem cell characteristics and development of a prognostic stemness index cell-related signature in oral squamous cell carcinoma. Dis. Markers 1571421 (2021).","DOI":"10.1155\/2021\/1571421"},{"key":"96821_CR35","doi-asserted-by":"publisher","first-page":"775562","DOI":"10.3389\/fmolb.2021.775562","volume":"8","author":"D Dai","year":"2021","unstructured":"Dai, D. et al. Combination of radiosensitivity gene signature and PD-L1 status predicts clinical outcome of patients with locally advanced head and neck squamous cell carcinoma: A study based on the cancer genome atlas dataset. Front. Mol. Biosci. 8, 775562 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"96821_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hed.26474","volume":"43","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma. Head Neck. 43, 182\u2013197 (2021).","journal-title":"Head Neck"},{"key":"96821_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.csbj.2021.01.046","volume":"19","author":"W Qiang","year":"2021","unstructured":"Qiang, W., Dai, Y., Xing, X. & Sun, X. Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma. Comput. Struct. Biotechnol. J. 19, 1263\u20131276 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"96821_CR38","doi-asserted-by":"publisher","first-page":"809872","DOI":"10.3389\/fimmu.2022.809872","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A signature of N(6)-methyladenosine regulator-related genes predicts prognoses and immune responses for head and neck squamous cell carcinoma. Front. Immunol. 13, 809872 (2022).","journal-title":"Front. Immunol."},{"key":"96821_CR39","doi-asserted-by":"publisher","first-page":"117906","DOI":"10.1016\/j.lfs.2020.117906","volume":"256","author":"J Yang","year":"2020","unstructured":"Yang, J., Xie, K. & Li, C. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma. Life Sci. 256, 117906 (2020).","journal-title":"Life Sci."},{"key":"96821_CR40","doi-asserted-by":"publisher","first-page":"586344","DOI":"10.3389\/fmolb.2020.586344","volume":"7","author":"J Long","year":"2020","unstructured":"Long, J. et al. Development of an Immunogenomic landscape-based prognostic index of head and neck squamous cell carcinoma. Front. Mol. Biosci. 7, 586344 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"96821_CR41","first-page":"4485","volume":"25","author":"Y Liang","year":"2019","unstructured":"Liang, Y. et al. An Inflammation-Immunity classifier of 11 chemokines for prediction of overall survival in head and neck squamous cell carcinoma. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 25, 4485\u20134494 (2019).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"96821_CR42","doi-asserted-by":"publisher","first-page":"833771","DOI":"10.3389\/fmolb.2022.833771","volume":"9","author":"N Chen","year":"2022","unstructured":"Chen, N., He, D., Cui, J. A. & Neutrophil Extracellular Traps signature predicts the clinical outcomes and immunotherapy response in head and neck squamous cell carcinoma. Front. Mol. Biosci. 9, 833771 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"96821_CR43","doi-asserted-by":"publisher","first-page":"788671","DOI":"10.3389\/fonc.2021.788671","volume":"11","author":"J Li","year":"2021","unstructured":"Li, J. et al. Identification of the Nerve-Cancer Cross-Talk-Related prognostic gene model in head and neck squamous cell carcinoma. Front. Oncol. 11, 788671 (2021).","journal-title":"Front. Oncol."},{"key":"96821_CR44","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.21037\/atm-21-4712","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Ann. Transl Med. 9, 1554 (2021).","journal-title":"Ann. Transl Med."},{"key":"96821_CR45","doi-asserted-by":"publisher","first-page":"710694","DOI":"10.3389\/fonc.2021.710694","volume":"11","author":"R Ming","year":"2021","unstructured":"Ming, R. et al. The prognostic value of the DNA repair gene signature in head and neck squamous cell carcinoma. Front. Oncol. 11, 710694 (2021).","journal-title":"Front. Oncol."},{"key":"96821_CR46","doi-asserted-by":"publisher","first-page":"739182","DOI":"10.3389\/fonc.2021.739182","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Luo, X., Yu, J., Qian, K. & Zhu, H. An immune feature-based, three-gene scoring system for prognostic prediction of head-and-neck squamous cell carcinoma. Front. Oncol. 11, 739182 (2021).","journal-title":"Front. Oncol."},{"key":"96821_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.omtn.2020.06.001","volume":"21","author":"L Yi","year":"2020","unstructured":"Yi, L., Wu, G., Guo, L., Zou, X. & Huang, P. Comprehensive analysis of the PD-L1 and immune infiltrates of m(6)A RNA methylation regulators in head and neck squamous cell carcinoma. Mol. Ther. Nucleic Acids. 21, 299\u2013314 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"96821_CR48","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1158\/1078-0432.CCR-19-3997","volume":"26","author":"B Feng","year":"2020","unstructured":"Feng, B. et al. Integrative analysis of Multi-omics data identified EGFR and PTGS2 as key nodes in a gene regulatory network related to immune phenotypes in head and neck cancer. Clin. cancer Res. Off J. Am. Assoc. Cancer Res. 26, 3616\u20133628 (2020).","journal-title":"Clin. cancer Res. Off J. Am. Assoc. Cancer Res."},{"key":"96821_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1078-0432.CCR-20-2166","volume":"27","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Li, Z. Y., Zhou, G. Q. & Sun, Y. An immune-related gene prognostic index for head and neck squamous cell carcinoma. Clin. cancer Res. Off J. Am. Assoc. Cancer Res. 27, 330\u2013341 (2021).","journal-title":"Clin. cancer Res. Off J. Am. Assoc. Cancer Res."},{"key":"96821_CR50","doi-asserted-by":"publisher","first-page":"795781","DOI":"10.3389\/fonc.2022.795781","volume":"12","author":"R Ming","year":"2022","unstructured":"Ming, R. et al. The prognostic signature of head and neck squamous cell carcinoma constructed by immune-related RNA-binding proteins. Front. Oncol. 12, 795781 (2022).","journal-title":"Front. Oncol."},{"key":"96821_CR51","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Identification of immune-related prognostic biomarkers associated with HPV-positive head and neck squamous cell carcinoma. J. Immunol. Res. 6661625 (2021).","DOI":"10.1155\/2021\/6661625"},{"key":"96821_CR52","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.2147\/IJGM.S354349","volume":"15","author":"Y Lu","year":"2022","unstructured":"Lu, Y. & Jia, Z. Inflammation-Related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. Int. J. Gen. Med. 15, 4793\u20134805 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"96821_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-022-09673-3","volume":"22","author":"Z Cai","year":"2022","unstructured":"Cai, Z., Tang, B., Chen, L. & Lei, W. Mast cell marker gene signature in head and neck squamous cell carcinoma. BMC Cancer. 22, 577 (2022).","journal-title":"BMC Cancer"},{"key":"96821_CR54","doi-asserted-by":"publisher","first-page":"570336","DOI":"10.3389\/fgene.2021.570336","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. A novel Immune-Related prognostic signature in head and neck squamous cell carcinoma. Front. Genet. 12, 570336 (2021).","journal-title":"Front. Genet."},{"key":"96821_CR55","doi-asserted-by":"publisher","first-page":"905635","DOI":"10.3389\/fimmu.2022.905635","volume":"13","author":"X Tang","year":"2022","unstructured":"Tang, X. et al. Development and validation of an ADME-Related gene signature for survival, treatment outcome and immune cell infiltration in head and neck squamous cell carcinoma. Front. Immunol. 13, 905635 (2022).","journal-title":"Front. Immunol."},{"key":"96821_CR56","doi-asserted-by":"publisher","first-page":"938611","DOI":"10.3389\/fgene.2022.938611","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang, S., Zhang, W. & Zhang, J. 8-Gene signature related to CD8(+) T cell infiltration by integrating single-cell and bulk RNA-sequencing in head and neck squamous cell carcinoma. Front. Genet. 13, 938611 (2022).","journal-title":"Front. Genet."},{"key":"96821_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","volume":"11","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors. J. Hematol. Oncol. 11, 104 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"96821_CR58","doi-asserted-by":"publisher","first-page":"1337129","DOI":"10.3389\/fimmu.2024.1337129","volume":"15","author":"C Lin","year":"2024","unstructured":"Lin, C. et al. Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma. Front. Immunol. 15, 1337129 (2024).","journal-title":"Front. Immunol."},{"key":"96821_CR59","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 41, 374\u2013403 (2023).","journal-title":"Cancer Cell."},{"key":"96821_CR60","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1038\/s41598-024-56738-3","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study. Sci. Rep. 14, 6390 (2024).","journal-title":"Sci. Rep."},{"key":"96821_CR61","doi-asserted-by":"crossref","unstructured":"Jung, F., Steger, S., Knapp, O., Noll, M. & Wesarg, S. C. O. S. M. O. - Coupled shape model for radiation therapy planning of head and neck cancer. In Clinical image-based procedures. translational research in medical imaging. CLIP 2014. Lecture Notes in Computer Science (eds Linguraru, M. et al.) 25\u201332 (Springer, 2014).","DOI":"10.1007\/978-3-319-13909-8_4"},{"key":"96821_CR62","doi-asserted-by":"crossref","unstructured":"Corti, A., Mainardi, L. & Corino, V. D. A. Assessing the performance of MRI-radiomic prognostic signatures in head and neck cancer patients: A comparative analysis. In MEDICON\u201923 and CMBEBIH\u201923 (eds. Badnjevi\u0107, A. & Gurbeta Pokvi\u0107, L.) 363\u2013368. (Springer Nature Switzerland, 2024).","DOI":"10.1007\/978-3-031-49068-2_37"},{"key":"96821_CR63","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison, N. J., Cook, P. A. & Gee, J. C. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging. 29, 1310\u20131320 (2010).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"96821_CR64","doi-asserted-by":"publisher","first-page":"20170498","DOI":"10.1259\/bjr.20170498","volume":"91","author":"RT Leijenaar","year":"2018","unstructured":"Leijenaar, R. T. et al. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study. Br. J. Radiol. 91, 20170498 (2018).","journal-title":"Br. J. Radiol."},{"key":"96821_CR65","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."},{"key":"96821_CR66","unstructured":"Pyradiomics features description. (2018)."},{"key":"96821_CR67","doi-asserted-by":"publisher","first-page":"D52","DOI":"10.1093\/nar\/gkq1237","volume":"39","author":"D Maglott","year":"2011","unstructured":"Maglott, D., Ostell, J., Pruitt, K. D. & Tatusova, T. Entrez gene: gene-centered information at NCBI. Nucleic Acids Res. 39, D52\u2013D57 (2011).","journal-title":"Nucleic Acids Res."},{"key":"96821_CR68","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. 1711, 243\u2013259 (2018).","journal-title":"Methods Mol. Biol."},{"key":"96821_CR69","doi-asserted-by":"crossref","unstructured":"Shutaywi, M. & Kachouie, N. N. Silhouette analysis for performance evaluation in machine learning with applications to clustering. Entropy (Basel) 23, (2021).","DOI":"10.3390\/e23060759"},{"key":"96821_CR70","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.1002\/ece3.5774","volume":"9","author":"A Lengyel","year":"2019","unstructured":"Lengyel, A. & Botta-Duk\u00e1t, Z. Silhouette width using generalized mean-A flexible method for assessing clustering efficiency. Ecol. Evol. 9, 13231\u201313243 (2019).","journal-title":"Ecol. Evol."},{"key":"96821_CR71","first-page":"321","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla, N. V., Bowyer, K. W., Hall, L. O. & Kegelmeyer, W. P. SMOTE: synthetic minority over-sampling technique. J. Artif. Int. Res. 16, 321\u2013357 (2002).","journal-title":"J. Artif. Int. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96821-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:04:39Z","timestamp":1744477479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96821-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96821-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocols were approved by the Ethical Committees of the participating centers, and data acquisition followed the General Data Protection Regulation of the EU. All patients signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript and agree with submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"12622"}}